Driven Brands (NASDAQ:DRVN) Upgraded by Morgan Stanley to Overweight

Driven Brands} stock has undergone multiple analysts rating changes in the recent past.  Driven Brands Upgraded by Morgan Stanley on 10/29/2021. In a note to investors, the firm issued a new rating of Overweight. The analysts previously had rating of Equal Weight.

View More Driven Brands (NASDAQ:DRVN) Upgraded by Morgan Stanley to Overweight

Nexa Resources (NYSE:NEXA) Downgraded by Morgan Stanley to Equal Weight

Nexa Resources} stock has undergone multiple analysts rating changes in the recent past.  Nexa Resources Downgraded by Morgan Stanley on 10/29/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Overweight.

View More Nexa Resources (NYSE:NEXA) Downgraded by Morgan Stanley to Equal Weight

Altria Group (NYSE:MO) Downgraded by Morgan Stanley to Equal Weight

Altria Group} stock has undergone multiple analysts rating changes in the recent past.  Altria Group Downgraded by Morgan Stanley on 10/29/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Overweight.

View More Altria Group (NYSE:MO) Downgraded by Morgan Stanley to Equal Weight

Intel (NASDAQ:INTC) Downgraded by Morgan Stanley to Equal Weight

Intel} stock has undergone multiple analysts rating changes in the recent past.  Intel Downgraded by Morgan Stanley on 10/22/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Overweight.

View More Intel (NASDAQ:INTC) Downgraded by Morgan Stanley to Equal Weight

Akero Therapeutics (NASDAQ:AKRO) Downgraded by Morgan Stanley to Equal Weight

Akero Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Akero Therapeutics Downgraded by Morgan Stanley on 10/19/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Overweight.

View More Akero Therapeutics (NASDAQ:AKRO) Downgraded by Morgan Stanley to Equal Weight

Kaleido Biosciences (NASDAQ:KLDO) Downgraded by Morgan Stanley to Underweight

Kaleido Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Kaleido Biosciences Downgraded by Morgan Stanley on 10/19/2021. In a note to investors, the firm issued a new rating of Underweight. The analysts previously had rating of Equal Weight.

View More Kaleido Biosciences (NASDAQ:KLDO) Downgraded by Morgan Stanley to Underweight

Xcel Energy (NASDAQ:XEL) Upgraded by Morgan Stanley to Equal Weight

Xcel Energy} stock has undergone multiple analysts rating changes in the recent past.  Xcel Energy Upgraded by Morgan Stanley on 10/19/2021. In a note to investors, the firm issued a new rating of Equal Weight. The analysts previously had rating of Underweight.

View More Xcel Energy (NASDAQ:XEL) Upgraded by Morgan Stanley to Equal Weight